Multi-country, non-interventional, cohort study of the effectiveness, safety, adherence, and health-related quality of life in HIV-1 infected adult patients receiving Bictegravir/ Emtricitabine/Tenofovir alafenamide (B/F/TAF) (BIC-STaR)

09/02/2018
17/09/2025
EU PAS number:
EUPAS22185
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

GS-EU-380-4472-appendix-16.1.1-protocol_f-redact

English (1.13 MB - PDF) View document
Updated protocol

GS-EU-380-4472-appendix-16.1.1-protocol amendment 4_f-redact.pdf

First published: 11/06/2025
English (2.46 MB - PDF) View document

GS-EU-380-4472-appendix-16.1.1-protocol amendment 4_f-redact

First published: 22/02/2024
English (2.46 MB - PDF) View document
Study results
Study report
Study report

GS-EU-380-4472_Abbreviated NIS_CSR_synopsis_f-redact.pdf

English (1.43 MB - PDF) View document
Other information